The competitive advantage of nations : the case of Guangxi, assessing Porter's framework for national advantage.

by Tan, Rudy., Tan, Eng Huat., Tan, Michelle., Wee, Bee Hua.
Published 2010

Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib

by Kannan, Srinivasaraghavan, Pradhan, Mohan R., Tiwari, Garima, Tan, Wei-Chong, Chowbay, Balram, Tan, Eng Huat, Tan, Daniel Shao-Weng, Verma, Chandra
Published 2017

Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).

by Fong, Pei Yuan, Tan, Sze Huey, Lim, Darren Wan Teck, Tan, Eng Huat, Ng, Quan Sing, Sommat, Kiattisa, Tan, Daniel Shao Weng, Ang, Mei Kim
Published 2022

Dynamic contrast-enhanced computed tomography in metastatic nasopharyngeal carcinoma : reproducibility analysis and observer variability of the distributed parameter model

by Ng, Quan-Sing, Thng, Choon Hua, Lim, Wan Teck, Hartono, Septian, Thian, Yee Liang, Lee, Puor Sherng, Tan, Daniel Shao-Weng, Tan, Eng Huat, Koh, Tong San
Published 2013

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

by Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel SW, Lim, Darren Wan-Teck
Published 2022

Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)

by Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel SW, Lim, Darren Wan-Teck
Published 2022

Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC

by Tan, Eng-Huat, Lim, Wan-Teck, Ahn, Myung-Ju, Ng, Quan-Sing, Ahn, Jin Seok, Tan, Daniel Shao-Weng, Sun, Jong-Mu, Han, May, Payumo, Francis C, Mckee, Krista, Yin, Wei, Credi, Marc, Agarwal, Shefali, Jac, Jaroslaw, Park, Keunchil
Published 2022

Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer (vol 17, 66, 2023)

by Lee, Ning-Yuan, Hum, Melissa, Zihara, Sabna, Wang, Lanying, Myint, Matthew K, Lim, Darren Wan-Teck, Toh, Chee-Keong, Skanderup, Anders, Samol, Jens, Tan, Min-Han, Ang, Peter, Lee, Soo-Chin, Tan, Eng-Huat, Lai, Gillianne GY, Tan, Daniel SW, Yap, Yoon-Sim, Lee, Ann SG
Published 2024

Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

by Lee, Ning-Yuan, Hum, Melissa, Zihara, Sabna, Wang, Lanying, Myint, Matthew K, Lim, Darren Wan-Teck, Toh, Chee-Keong, Skanderup, Anders, Samol, Jens, Tan, Min-Han, Ang, Peter, Lee, Soo-Chin, Tan, Eng-Huat, Lai, Gillianne GY, Tan, Daniel SW, Yap, Yoon-Sim, Lee, Ann SG
Published 2024

Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine...

by Ma, Jun, Tan, Sze Huey, Yin, Daniel Xing Cheng, Tran, Nguyen Tuan Anh, San Tan, Gek, Lai, Gillianne Geet Yi, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Rajasekaran, Tanujaa, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel Shao-Weng, Lim, Darren Wan-Teck, Ng, Quan Sing, Tan, Wan Ling
Published 2024

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma

by Lim, Darren Wan-Teck, Kao, Hsiang-Fong, Suteja, Lisda, Li, Constance H, Quah, Hong Sheng, Tan, Daniel Shao-Weng, Tan, Sze-Huey, Tan, Eng-Huat, Tan, Wan-Ling, Lee, Justina Nadia, Wee, Felicia Yu-Ting, Jain, Amit, Goh, Boon-Cher, Chua, Melvin LK, Liao, Bin-Chi, Ng, Quan Sing, Hong, Ruey-Long, Ang, Mei-Kim, Yeong, Joe Poh-Sheng, Iyer, N Gopalakrishna
Published 2024

Methionine is a metabolic dependency of tumor-initiating cells

by Wang, Zhenxun, Yip, Lian Yee, Lee, Jane Jia Hui, Wu, Zhengwei, Chew, Hui Yi, Chong, William Pooi Kiat, Teo, Chin Chye, Ang, Heather Yin-Kuan, Peh, Esther Kai Lay, Yuan, Ju, Ma, Siming, Choo, Kimberly Li Shi, Basri, Nurhidayah, Jiang, Xia, Yu, Qiang, Hillmer, Axel M., Lim, Wan Teck, Lim, Tony Kiat Hon, Takano, Angela, Tan, Eng Huat, Tan, Daniel Shao Weng, Ho, Ying Swan, Lim, Bing, Tam, Wai Leong
Published 2021

Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression

by Zhang, Wen Cai, Chin, Tan Min, Yang, Henry, Nga, Min En, Lunny, Declan Patrick, Lim, Edwin Kok Hao, Sun, Li Li, Pang, Yin Huei, Leow, Yi Ning, Malusay, Shanneen Rossellini Y, Lim, Priscilla Xin Hui, Lee, Jeravan Zili, Tan, Benedict Jian Wei, Ng, Shyh-Chang, Lim, Elaine Hsuen, Lim, Wan Teck, Tan, Daniel Shao Weng, Tan, Eng Huat, Tai, Bee Choo, Soo, Ross Andrew, Tam, Wai Leong, Lim, Bing
Published 2022

Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing

by Nahar, Rahul, Zhai, Weiwei, Zhang, Tong, Takano, Angela, Khng, Alexis J., Lee, Yin Yeng, Liu, Xingliang, Lim, Chong Hee, Koh, Tina P. T., Aung, Zaw Win, Lim, Tony Kiat Hon, Veeravalli, Lavanya, Yuan, Ju, Teo, Audrey S. M., Chan, Cheryl X., Poh, Huay Mei, Chua, Ivan M. L., Liew, Audrey Ann, Lau, Dawn Ping Xi, Kwang, Xue Lin, Toh, Chee Keong, Lim, Wan-Teck, Lim, Bing, Tam, Wai Leong, Tan, Eng-Huat, Hillmer, Axel M., Tan, Daniel S. W.
Published 2018

Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience

by Seet, Amanda OL, Tan, Aaron C, Tan, Tira J, Ng, Matthew CH, Tai, David WM, Lam, Justina YC, San Tan, Gek, Gogna, Apoorva, Too, Chow Wei, Tan, Bien Soo, Takano, Angela, Lim, Alvin, Lim, Tse Hui, Lim, Soon Thye, Dent, Rebecca Alexandra, Ang, Mei Kim, Yap, Yoon-Sim, Tan, Iain BH, Choo, Su Pin, Toh, Chee Keong, Lim, Elaine H, Farid, Mohamad, Skanderup, Anders Jacobsen, Iyer, N Gopalakrishna, Lim, Wan Teck, Tan, Eng Huat, Lim, Tony KH, Tan, Daniel SW
Published 2024

A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC

by Lai, Gillianne GY, Yeo, Jia Chi, Jain, Amit, Zhou, Siqin, Pang, Mengyuan, Alvarez, Jacob JS, Sim, Ngak Leng, Tan, Aaron C, Suteja, Lisda, Lim, Tze Wei, Guo, Yu Amanda, Shen, Meixin, Saw, Stephanie PL, Rohatgi, Neha, Yeong, Joe PS, Takano, Angela, Lim, Kiat Hon, Gogna, Apoorva, Too, Chow Wei, Da Zhuang, Kun, Tan, Wan Ling, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Wang, Lanying, Toh, Chee Keong, Lim, Wan-Teck, Tam, Wai Leong, Tan, Sze Huey, Skanderup, Anders MJ, Tan, Eng-Huat, Tan, Daniel SW
Published 2024

Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities

by Chua, Khi Pin, Teng, Yvonne HF, Tan, Aaron C, Takano, Angela, Alvarez, Jacob JS, Nahar, Rahul, Rohatgi, Neha, Lai, Gillianne GY, Aung, Zaw Win, Yeong, Joe PS, Lim, Kiat Hon, Naeini, Marjan Mojtabavi, Kassam, Irfahan, Jain, Amit, Tan, Wan Ling, Gogna, Apoorva, Too, Chow Wei, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Anantham, Devanand, Phua, Ghee Chee, Tan, Bien Soo, Lee, Yin Yeng, Wang, Lanying, Teo, Audrey SM, Khng, Alexis Jiaying, Lim, Ming Jie, Suteja, Lisda, Toh, Chee Keong, Lim, Wan-Teck, Iyer, N Gopalakrishna, Tam, Wai Leong, Tan, Eng-Huat, Zhai, Weiwei, Hillmer, Axel M, Skanderup, Anders J, Tan, Daniel SW
Published 2024